Pharmacological Profile
Mesocarb (Mesocarbum) belongs to a specific group of psychostimulants known as sydnimine derivatives.
The drug exhibits pronounced pharmacological activity, but its key feature is revealed when compared to classic stimulants. When contrasted with amphetamine (which belongs to phenylalkylamine derivatives), mesocarb demonstrates a milder psychostimulating effect. At the same time, its safety profile is more favorable: the drug exerts a less pronounced negative impact on the autonomic functions of the body.
Mechanism of Action
The primary site of action is localized within the central nervous system (CNS). Peripheral sympathomimetic effects are extremely minimal, which largely determines its safety profile for the cardiovascular system.
At the microscopic level, the mechanism of action unfolds as follows:
- The drug acts on the presynaptic terminals of neurons.
- There is an active displacement of the neurotransmitter norepinephrine from its storage sites — the presynaptic vesicles.
- The released norepinephrine enters directly into the synaptic cleft.
- The result of this process is a potent activation of noradrenergic neurotransmission.
Characteristics of the Psychostimulatory Effect
The action of mesocarb is typically described as "mild." Unlike the effects of amphetamines, the clinical picture upon taking sydnimine derivatives has several fundamental differences:
- Gradual Onset: The stimulating effect develops progressively rather than abruptly.
- Absence of Euphoria: The drug lacks the initial euphoric phase typical of amphetamines.
- Preservation of Energy Balance: A crucial advantage is that it does not cause a "crash" phenomenon—meaning subsequent exhaustion of the body's energy reserves after the drug wears off.
- Low Addiction Potential: Drug dependence on mesocarb develops significantly slower than on phenylalkylamine derivatives.
Clinical Use
Given the drug's ability to gently activate the CNS without subsequent exhaustion, it is prescribed for conditions requiring increased vitality. The main indications include:
- General fatigue and various asthenic states.
- Narcolepsy (a condition accompanied by pathological sleepiness).
- Subdepressive states.
Side Effects and Precautions
Although mesocarb is less likely to provoke elevated blood pressure compared to traditional sympathomimetics, it can still cause several adverse reactions.
- Psychoneurological sphere: Patients may experience internal anxiety and increased irritability. Crucial rule: The drug is strictly not recommended to be administered in the evening, as this will inevitably lead to insomnia.
- Autonomic and somatic manifestations: Elevated blood pressure, hyperthermia, constipation, and an anorexigenic effect (marked loss of appetite) are possible.
- Immune system: Various allergic reactions may occur.